ROCHESTER, Minn. & DANVERS, Mass.--(BUSINESS WIRE)--Sonex Health, the creator of the SX-One MicroKnife® with Meerkat Technology® has announced a co-marketing agreement with Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd. This relationship will position Sonex Health and Samsung NeuroLogica as leaders in ultrasound-guided micro-invasive procedures. Under this agreement, the two companies will promote the importance of using high-quality ultrasound imaging during micro-invasive procedures to optimize outcomes, enhance the patient experience and drive practice efficiencies.
“We are excited to partner with Sonex Health to deliver disruptive and innovative treatment solutions that result in better outcomes with improved efficiency,” said Philip Sullivan, President and Chief Executive Officer of Samsung NeuroLogica. “Using our exquisite image quality in combination with Sonex Health’s elegant techniques to reduce surgical trauma, we can impact the lives of those who suffer debilitating pain and get them relief much faster.”
The SX-One MicroKnife® enables micro-invasive carpal tunnel release (CTR) through a micro-incision that is up to five times smaller than the incision made during traditional CTR surgeries1—an incision so small, it can be closed with an adhesive bandage or strip. High-quality musculoskeletal ultrasound imaging is a key component for this procedure. Ultrasound guidance allows real-time visualization of the surrounding critical anatomy in relationship to the device during this procedure, helping protect patient anatomy and promoting rapid recovery2,3.
“By refining, simplifying and thinking differently, we have created a better way to treat patients suffering with carpal tunnel syndrome. Using the SX-One MicroKnife® with ultrasound guidance may result in a faster and easier recovery for patients, as well as overall reduced costs,” said Darryl Barnes, MD, Chief Executive Officer and Co-Founder of Sonex Health. “We believe that this partnership with Samsung NeuroLogica, a leader in high-quality ultrasound imaging, will significantly contribute to an enhanced quality of life for millions of people.”
About Sonex Health
Sonex Health is a medical device company created by physicians and healthcare leaders at Mayo Clinic with expertise in ultrasound imaging, ultrasound-guided micro-incision interventional procedures, and health care administration. The company is at the leading edge of micro-invasive surgical procedures that can be performed cost-effectively in an office or ambulatory surgery center setting. Sonex Health is focused on the safe, rapid treatment of carpal tunnel syndrome, a condition that affects 12 million Americans each year and is one of the leading causes of lost productivity in the economy.
Sonex Health is located in Rochester, MN. For more information, please visit www.SonexHealth.com.
About Samsung NeuroLogica
Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd, develops, manufactures and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit, www.SamsungNeurologica.com.
1. Papatheodorou LK, Sotereanos DG. Treatment recommendations for carpal
tunnel syndrome and peripheral nerve repair. Instr Course Lect. 2015;
2. Nakamichi K, Tachibana S, Ida M. Percutaneous carpal tunnel release compared with mini-open release using ultra sonographic guidance for both techniques. J Hand Surg. 2010;35A:437-445.
3. Rojo-Manaute JM, Capa-Grasa A, et al. Ultra-minimally invasive sonographically guided carpal tunnel release: a randomized clinical trial. J Ultrasound Med. 2016;37:e37-45.